

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 9.79615441 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 9.79615441 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 7.57585332 |
| 4 | cellular potassium ion homeostasis (GO:0030007) | 6.18393790 |
| 5 | fatty acid elongation (GO:0030497) | 5.91430372 |
| 6 | myelination (GO:0042552) | 5.86616009 |
| 7 | axon ensheathment (GO:0008366) | 5.86349434 |
| 8 | ensheathment of neurons (GO:0007272) | 5.86349434 |
| 9 | sodium ion export (GO:0071436) | 5.71254267 |
| 10 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.48723076 |
| 11 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.24837410 |
| 12 | neurotransmitter secretion (GO:0007269) | 5.11040320 |
| 13 | regulation of synaptic vesicle transport (GO:1902803) | 5.01938931 |
| 14 | positive regulation of synapse maturation (GO:0090129) | 4.95713226 |
| 15 | L-amino acid import (GO:0043092) | 4.66600982 |
| 16 | potassium ion homeostasis (GO:0055075) | 4.44194688 |
| 17 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.39127492 |
| 18 | negative regulation of neurotransmitter transport (GO:0051589) | 4.37428009 |
| 19 | presynaptic membrane organization (GO:0097090) | 4.28563467 |
| 20 | potassium ion import (GO:0010107) | 4.17192190 |
| 21 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.15368043 |
| 22 | neurotransmitter transport (GO:0006836) | 4.12423558 |
| 23 | presynaptic membrane assembly (GO:0097105) | 4.07577832 |
| 24 | neuronal action potential propagation (GO:0019227) | 4.02454786 |
| 25 | neuron cell-cell adhesion (GO:0007158) | 4.01129858 |
| 26 | myelin maintenance (GO:0043217) | 3.99255391 |
| 27 | transmission of nerve impulse (GO:0019226) | 3.97629572 |
| 28 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.94749247 |
| 29 | glycerophospholipid catabolic process (GO:0046475) | 3.91740507 |
| 30 | exploration behavior (GO:0035640) | 3.91401500 |
| 31 | establishment of mitochondrion localization (GO:0051654) | 3.90575527 |
| 32 | postsynaptic membrane organization (GO:0001941) | 3.88594308 |
| 33 | oligodendrocyte differentiation (GO:0048709) | 3.84714104 |
| 34 | neuromuscular process controlling balance (GO:0050885) | 3.84335247 |
| 35 | regulation of synaptic plasticity (GO:0048167) | 3.83343305 |
| 36 | negative regulation of protein localization to cell surface (GO:2000009) | 3.79932896 |
| 37 | apical protein localization (GO:0045176) | 3.79503825 |
| 38 | regulation of synapse maturation (GO:0090128) | 3.72979227 |
| 39 | adult walking behavior (GO:0007628) | 3.72671887 |
| 40 | regulation of collateral sprouting (GO:0048670) | 3.71578610 |
| 41 | regulation of neurotransmitter levels (GO:0001505) | 3.70544292 |
| 42 | synaptic vesicle maturation (GO:0016188) | 3.60907636 |
| 43 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.58983205 |
| 44 | cell communication by electrical coupling (GO:0010644) | 3.58613107 |
| 45 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.57830638 |
| 46 | synaptic vesicle endocytosis (GO:0048488) | 3.57468157 |
| 47 | regulation of ARF protein signal transduction (GO:0032012) | 3.56958506 |
| 48 | regulation of neurotransmitter secretion (GO:0046928) | 3.56245180 |
| 49 | response to methylmercury (GO:0051597) | 3.55908386 |
| 50 | regulation of synapse structural plasticity (GO:0051823) | 3.54699078 |
| 51 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.53832091 |
| 52 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.51829865 |
| 53 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.50957493 |
| 54 | positive regulation of dendritic spine development (GO:0060999) | 3.49288758 |
| 55 | amino acid import (GO:0043090) | 3.48574347 |
| 56 | astrocyte development (GO:0014002) | 3.45270655 |
| 57 | asymmetric protein localization (GO:0008105) | 3.44364405 |
| 58 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.43528876 |
| 59 | acidic amino acid transport (GO:0015800) | 3.43450480 |
| 60 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.41898293 |
| 61 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.41350473 |
| 62 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.40664354 |
| 63 | substantia nigra development (GO:0021762) | 3.39578840 |
| 64 | cellular sodium ion homeostasis (GO:0006883) | 3.37838931 |
| 65 | layer formation in cerebral cortex (GO:0021819) | 3.37638398 |
| 66 | cholesterol biosynthetic process (GO:0006695) | 3.36991038 |
| 67 | photoreceptor cell differentiation (GO:0046530) | 3.36712058 |
| 68 | eye photoreceptor cell differentiation (GO:0001754) | 3.36712058 |
| 69 | long-term memory (GO:0007616) | 3.34632609 |
| 70 | neuronal ion channel clustering (GO:0045161) | 3.33537990 |
| 71 | regulation of neurotransmitter transport (GO:0051588) | 3.30035375 |
| 72 | creatine metabolic process (GO:0006600) | 3.27285132 |
| 73 | dendritic spine morphogenesis (GO:0060997) | 3.26093412 |
| 74 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.25468448 |
| 75 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.23060405 |
| 76 | locomotory exploration behavior (GO:0035641) | 3.21376282 |
| 77 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.20384958 |
| 78 | cerebellar granule cell differentiation (GO:0021707) | 3.19214550 |
| 79 | synaptic vesicle exocytosis (GO:0016079) | 3.18509785 |
| 80 | neuromuscular synaptic transmission (GO:0007274) | 3.16477927 |
| 81 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.13230798 |
| 82 | regulation of vesicle fusion (GO:0031338) | 3.11451638 |
| 83 | long-term synaptic potentiation (GO:0060291) | 3.10180906 |
| 84 | negative regulation of axonogenesis (GO:0050771) | 3.09879639 |
| 85 | cerebellar Purkinje cell layer development (GO:0021680) | 3.07932385 |
| 86 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.07773191 |
| 87 | import into cell (GO:0098657) | 3.04957039 |
| 88 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.04667225 |
| 89 | L-glutamate transport (GO:0015813) | 3.04023471 |
| 90 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.04011711 |
| 91 | positive regulation of neurotransmitter transport (GO:0051590) | 3.03846431 |
| 92 | regulation of postsynaptic membrane potential (GO:0060078) | 3.03750850 |
| 93 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.03096787 |
| 94 | response to redox state (GO:0051775) | 3.02191243 |
| 95 | regulation of synaptic transmission (GO:0050804) | 3.01465157 |
| 96 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.00108640 |
| 97 | neuron recognition (GO:0008038) | 2.99691341 |
| 98 | peripheral nervous system axon ensheathment (GO:0032292) | 2.98925867 |
| 99 | myelination in peripheral nervous system (GO:0022011) | 2.98925867 |
| 100 | activation of protein kinase A activity (GO:0034199) | 2.98078274 |
| 101 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.97951214 |
| 102 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.97362020 |
| 103 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.96053363 |
| 104 | sterol biosynthetic process (GO:0016126) | 2.95592852 |
| 105 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.94760557 |
| 106 | glutamate receptor signaling pathway (GO:0007215) | 2.93695564 |
| 107 | glutamate secretion (GO:0014047) | 2.93086947 |
| 108 | membrane tubulation (GO:0097320) | 2.92908361 |
| 109 | nerve growth factor signaling pathway (GO:0038180) | 2.91521061 |
| 110 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.89621529 |
| 111 | neuron-neuron synaptic transmission (GO:0007270) | 2.88878931 |
| 112 | dicarboxylic acid transport (GO:0006835) | 2.88857293 |
| 113 | cell communication involved in cardiac conduction (GO:0086065) | 2.87772116 |
| 114 | synaptic transmission, glutamatergic (GO:0035249) | 2.87568450 |
| 115 | neuromuscular process (GO:0050905) | 2.86959376 |
| 116 | protein localization to synapse (GO:0035418) | 2.84446398 |
| 117 | isoprenoid biosynthetic process (GO:0008299) | 2.84215208 |
| 118 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.83754770 |
| 119 | membrane depolarization during action potential (GO:0086010) | 2.83554927 |
| 120 | glycine transport (GO:0015816) | 2.82691417 |
| 121 | vesicle docking involved in exocytosis (GO:0006904) | 2.82221049 |
| 122 | neurotransmitter uptake (GO:0001504) | 2.81852180 |
| 123 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.81121412 |
| 124 | vocalization behavior (GO:0071625) | 2.81079150 |
| 125 | neuron remodeling (GO:0016322) | 2.80981790 |
| 126 | synaptic transmission (GO:0007268) | 2.80962165 |
| 127 | gamma-aminobutyric acid transport (GO:0015812) | 2.79694579 |
| 128 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.79176693 |
| 129 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.77435742 |
| 130 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.75124780 |
| 131 | amyloid precursor protein metabolic process (GO:0042982) | 2.70739733 |
| 132 | positive regulation of membrane potential (GO:0045838) | 2.70305522 |
| 133 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.65666671 |
| 134 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.65666671 |
| 135 | negative regulation of axon extension (GO:0030517) | 2.65054653 |
| 136 | axonal fasciculation (GO:0007413) | 2.64753192 |
| 137 | cellular response to epinephrine stimulus (GO:0071872) | 2.60214412 |
| 138 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.60115856 |
| 139 | negative regulation of synaptic transmission (GO:0050805) | 2.59864947 |
| 140 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.59502993 |
| 141 | magnesium ion transport (GO:0015693) | 2.57307819 |
| 142 | regulation of catecholamine metabolic process (GO:0042069) | 2.57280428 |
| 143 | regulation of dopamine metabolic process (GO:0042053) | 2.57280428 |
| 144 | axon development (GO:0061564) | 2.57245144 |
| 145 | peripheral nervous system development (GO:0007422) | 2.55088205 |
| 146 | adult locomotory behavior (GO:0008344) | 2.53857244 |
| 147 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.53323031 |
| 148 | mating behavior (GO:0007617) | 2.53244411 |
| 149 | neuromuscular process controlling posture (GO:0050884) | 2.53155522 |
| 150 | regulation of dendritic spine development (GO:0060998) | 2.52846982 |
| 151 | Golgi to endosome transport (GO:0006895) | 2.51973801 |
| 152 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.51825160 |
| 153 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.51342206 |
| 154 | membrane hyperpolarization (GO:0060081) | 2.50513704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.71060444 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.57172326 |
| 3 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.46263718 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.92685765 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.86301513 |
| 6 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.81989986 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.73867601 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.44570887 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.44570887 |
| 10 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.36659014 |
| 11 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.35880464 |
| 12 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.32323966 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.31140648 |
| 14 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.30994261 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.28634241 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.27710486 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.26101355 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.25997032 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.24929883 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.20677335 |
| 21 | KDM2B_26808549_Chip-Seq_K562_Human | 2.16511904 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.14988061 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.14001167 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.10126578 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.10085977 |
| 26 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 2.09088074 |
| 27 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.07063290 |
| 28 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 2.04005036 |
| 29 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.02061768 |
| 30 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.00504810 |
| 31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.96235007 |
| 32 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.96073350 |
| 33 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.92681453 |
| 34 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.88323227 |
| 35 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.88282141 |
| 36 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.86198678 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.82393051 |
| 38 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.82029703 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.72672249 |
| 40 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.70555128 |
| 41 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.69168603 |
| 42 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.67645528 |
| 43 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.64469589 |
| 44 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.64439652 |
| 45 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.64296428 |
| 46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.62816345 |
| 47 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.62564671 |
| 48 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.56085749 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.55610778 |
| 50 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.55607233 |
| 51 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.53609330 |
| 52 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.51928066 |
| 53 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.51447326 |
| 54 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.50514778 |
| 55 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.48717663 |
| 56 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.48617333 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.46478531 |
| 58 | VDR_22108803_ChIP-Seq_LS180_Human | 1.46212078 |
| 59 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.45703431 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.43380260 |
| 61 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.42156434 |
| 62 | P300_19829295_ChIP-Seq_ESCs_Human | 1.41686216 |
| 63 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40175513 |
| 64 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.39245523 |
| 65 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.38912822 |
| 66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.38052688 |
| 67 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.36398432 |
| 68 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36006540 |
| 69 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33965416 |
| 70 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.33316506 |
| 71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32122147 |
| 72 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.30000864 |
| 73 | P68_20966046_ChIP-Seq_HELA_Human | 1.28342157 |
| 74 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.27716439 |
| 75 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.25840618 |
| 76 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.25781145 |
| 77 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.24994329 |
| 78 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24309932 |
| 79 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.24129523 |
| 80 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.24012517 |
| 81 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.22770487 |
| 82 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.22377849 |
| 83 | FUS_26573619_Chip-Seq_HEK293_Human | 1.22374308 |
| 84 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22015507 |
| 85 | STAT3_23295773_ChIP-Seq_U87_Human | 1.21665554 |
| 86 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21613333 |
| 87 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.21326664 |
| 88 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.20716309 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.17638656 |
| 90 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.17244692 |
| 91 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16402131 |
| 92 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.15546967 |
| 93 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.15031240 |
| 94 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11793129 |
| 95 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.10599884 |
| 96 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10560584 |
| 97 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10292869 |
| 98 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.09861359 |
| 99 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09300126 |
| 100 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09261463 |
| 101 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08999365 |
| 102 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 1.07532133 |
| 103 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07436652 |
| 104 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.06275967 |
| 105 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06160774 |
| 106 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.05676957 |
| 107 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05618387 |
| 108 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.05029561 |
| 109 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04929226 |
| 110 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03573501 |
| 111 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03236569 |
| 112 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02896519 |
| 113 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02841651 |
| 114 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.02760765 |
| 115 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02275081 |
| 116 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02043895 |
| 117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.01898755 |
| 118 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.01898755 |
| 119 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.01648688 |
| 120 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01155022 |
| 121 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00686708 |
| 122 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.00422635 |
| 123 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.00264789 |
| 124 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99860969 |
| 125 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.97714700 |
| 126 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97683206 |
| 127 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97614173 |
| 128 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.97265571 |
| 129 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.96943395 |
| 130 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96725303 |
| 131 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95772110 |
| 132 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95718965 |
| 133 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.93517349 |
| 134 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.92823906 |
| 135 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.92543568 |
| 136 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.92367627 |
| 137 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.90944475 |
| 138 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90742248 |
| 139 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90668078 |
| 140 | AR_25329375_ChIP-Seq_VCAP_Human | 0.90248640 |
| 141 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.90066566 |
| 142 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.89890848 |
| 143 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89602748 |
| 144 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89274986 |
| 145 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.89043068 |
| 146 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88622325 |
| 147 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.88598637 |
| 148 | AR_19668381_ChIP-Seq_PC3_Human | 0.88554487 |
| 149 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.88418353 |
| 150 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87384916 |
| 151 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87142242 |
| 152 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.87131919 |
| 153 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.86928114 |
| 154 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86805905 |
| 155 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.86479107 |
| 156 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86205747 |
| 157 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.85717353 |
| 158 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.85648701 |
| 159 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.85547790 |
| 160 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.84685839 |
| 161 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.83870201 |
| 162 | * SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.83076326 |
| 163 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.82730512 |
| 164 | SA1_27219007_Chip-Seq_Bcells_Human | 0.81271412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.97957933 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.47591047 |
| 3 | MP0000920_abnormal_myelination | 4.34538576 |
| 4 | MP0004270_analgesia | 3.72702064 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.00592133 |
| 6 | MP0002272_abnormal_nervous_system | 2.96641561 |
| 7 | MP0002064_seizures | 2.94719117 |
| 8 | MP0001486_abnormal_startle_reflex | 2.84801756 |
| 9 | MP0009745_abnormal_behavioral_response | 2.75156810 |
| 10 | MP0003690_abnormal_glial_cell | 2.64410697 |
| 11 | MP0009046_muscle_twitch | 2.64172723 |
| 12 | MP0001529_abnormal_vocalization | 2.57830281 |
| 13 | MP0003329_amyloid_beta_deposits | 2.56639317 |
| 14 | MP0004885_abnormal_endolymph | 2.50143031 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.46463504 |
| 16 | MP0005171_absent_coat_pigmentation | 2.36240490 |
| 17 | MP0002063_abnormal_learning/memory/cond | 2.29969414 |
| 18 | MP0004742_abnormal_vestibular_system | 2.23879692 |
| 19 | MP0002822_catalepsy | 2.21109511 |
| 20 | MP0000778_abnormal_nervous_system | 2.15827631 |
| 21 | MP0001905_abnormal_dopamine_level | 2.14234558 |
| 22 | MP0002572_abnormal_emotion/affect_behav | 2.13608976 |
| 23 | MP0003950_abnormal_plasma_membrane | 2.12211967 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 2.10983956 |
| 25 | MP0004142_abnormal_muscle_tone | 2.06158287 |
| 26 | MP0003634_abnormal_glial_cell | 1.95884310 |
| 27 | MP0001485_abnormal_pinna_reflex | 1.92521600 |
| 28 | MP0001968_abnormal_touch/_nociception | 1.79699716 |
| 29 | MP0003123_paternal_imprinting | 1.79494214 |
| 30 | MP0001440_abnormal_grooming_behavior | 1.78642686 |
| 31 | MP0003136_yellow_coat_color | 1.76430216 |
| 32 | MP0008569_lethality_at_weaning | 1.71770155 |
| 33 | MP0002229_neurodegeneration | 1.69376640 |
| 34 | MP0005409_darkened_coat_color | 1.65424090 |
| 35 | MP0001970_abnormal_pain_threshold | 1.64099093 |
| 36 | MP0002067_abnormal_sensory_capabilities | 1.62920269 |
| 37 | MP0003632_abnormal_nervous_system | 1.62135077 |
| 38 | MP0000751_myopathy | 1.61726715 |
| 39 | MP0000955_abnormal_spinal_cord | 1.60142236 |
| 40 | MP0002882_abnormal_neuron_morphology | 1.50942548 |
| 41 | MP0004924_abnormal_behavior | 1.50794044 |
| 42 | MP0005386_behavior/neurological_phenoty | 1.50794044 |
| 43 | MP0003631_nervous_system_phenotype | 1.49315657 |
| 44 | MP0003633_abnormal_nervous_system | 1.46459934 |
| 45 | MP0002733_abnormal_thermal_nociception | 1.45923753 |
| 46 | MP0002066_abnormal_motor_capabilities/c | 1.45693729 |
| 47 | MP0003787_abnormal_imprinting | 1.43378445 |
| 48 | MP0002735_abnormal_chemical_nociception | 1.43209318 |
| 49 | MP0005410_abnormal_fertilization | 1.42150868 |
| 50 | MP0002736_abnormal_nociception_after | 1.37382200 |
| 51 | MP0004043_abnormal_pH_regulation | 1.37080469 |
| 52 | MP0000749_muscle_degeneration | 1.36442172 |
| 53 | MP0001501_abnormal_sleep_pattern | 1.34296793 |
| 54 | MP0005551_abnormal_eye_electrophysiolog | 1.29246919 |
| 55 | MP0000604_amyloidosis | 1.26485230 |
| 56 | MP0002184_abnormal_innervation | 1.19806605 |
| 57 | MP0001963_abnormal_hearing_physiology | 1.18622053 |
| 58 | MP0010678_abnormal_skin_adnexa | 1.15443157 |
| 59 | MP0002557_abnormal_social/conspecific_i | 1.14645830 |
| 60 | MP0000462_abnormal_digestive_system | 1.13602780 |
| 61 | MP0004381_abnormal_hair_follicle | 1.11344066 |
| 62 | MP0004145_abnormal_muscle_electrophysio | 1.10698056 |
| 63 | MP0001177_atelectasis | 1.07974585 |
| 64 | MP0005623_abnormal_meninges_morphology | 1.07581118 |
| 65 | MP0000579_abnormal_nail_morphology | 1.07367692 |
| 66 | MP0004811_abnormal_neuron_physiology | 1.07126614 |
| 67 | MP0002752_abnormal_somatic_nervous | 1.06258578 |
| 68 | MP0001299_abnormal_eye_distance/ | 1.04698354 |
| 69 | MP0002152_abnormal_brain_morphology | 0.99200528 |
| 70 | MP0008260_abnormal_autophagy | 0.97628933 |
| 71 | MP0000747_muscle_weakness | 0.97241559 |
| 72 | MP0004134_abnormal_chest_morphology | 0.96730621 |
| 73 | MP0001346_abnormal_lacrimal_gland | 0.95536034 |
| 74 | MP0001986_abnormal_taste_sensitivity | 0.95222179 |
| 75 | MP0000383_abnormal_hair_follicle | 0.92169478 |
| 76 | MP0005646_abnormal_pituitary_gland | 0.91597000 |
| 77 | MP0009780_abnormal_chondrocyte_physiolo | 0.91256966 |
| 78 | MP0004233_abnormal_muscle_weight | 0.90141250 |
| 79 | MP0004130_abnormal_muscle_cell | 0.86449012 |
| 80 | MP0005451_abnormal_body_composition | 0.84969332 |
| 81 | MP0004147_increased_porphyrin_level | 0.84684765 |
| 82 | MP0001502_abnormal_circadian_rhythm | 0.83874433 |
| 83 | MP0005645_abnormal_hypothalamus_physiol | 0.83755578 |
| 84 | MP0000759_abnormal_skeletal_muscle | 0.80697095 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.77091919 |
| 86 | MP0003938_abnormal_ear_development | 0.77027944 |
| 87 | MP0005195_abnormal_posterior_eye | 0.75023037 |
| 88 | MP0002090_abnormal_vision | 0.74612462 |
| 89 | MP0008874_decreased_physiological_sensi | 0.72293067 |
| 90 | MP0004087_abnormal_muscle_fiber | 0.71627343 |
| 91 | MP0000026_abnormal_inner_ear | 0.70789035 |
| 92 | MP0010234_abnormal_vibrissa_follicle | 0.70657822 |
| 93 | MP0001188_hyperpigmentation | 0.69900338 |
| 94 | MP0001984_abnormal_olfaction | 0.69047839 |
| 95 | MP0003122_maternal_imprinting | 0.67732284 |
| 96 | MP0006276_abnormal_autonomic_nervous | 0.67215493 |
| 97 | MP0003137_abnormal_impulse_conducting | 0.66941269 |
| 98 | MP0005535_abnormal_body_temperature | 0.66580281 |
| 99 | MP0003075_altered_response_to | 0.66449689 |
| 100 | MP0003705_abnormal_hypodermis_morpholog | 0.63158983 |
| 101 | MP0000631_abnormal_neuroendocrine_gland | 0.62256957 |
| 102 | MP0001661_extended_life_span | 0.61874663 |
| 103 | MP0002909_abnormal_adrenal_gland | 0.61590796 |
| 104 | MP0001851_eye_inflammation | 0.61533178 |
| 105 | MP0002269_muscular_atrophy | 0.61278513 |
| 106 | MP0004858_abnormal_nervous_system | 0.60909316 |
| 107 | MP0004085_abnormal_heartbeat | 0.60714272 |
| 108 | MP0002295_abnormal_pulmonary_circulatio | 0.59627747 |
| 109 | MP0002069_abnormal_eating/drinking_beha | 0.59184131 |
| 110 | MP0001348_abnormal_lacrimal_gland | 0.58771566 |
| 111 | MP0000566_synostosis | 0.57776807 |
| 112 | MP0002638_abnormal_pupillary_reflex | 0.57399806 |
| 113 | MP0005253_abnormal_eye_physiology | 0.56096956 |
| 114 | MP0004036_abnormal_muscle_relaxation | 0.55802116 |
| 115 | MP0010769_abnormal_survival | 0.55565915 |
| 116 | MP0006072_abnormal_retinal_apoptosis | 0.54603844 |
| 117 | MP0000647_abnormal_sebaceous_gland | 0.54313166 |
| 118 | MP0001943_abnormal_respiration | 0.53971299 |
| 119 | MP0002249_abnormal_larynx_morphology | 0.53509077 |
| 120 | MP0001664_abnormal_digestion | 0.52707643 |
| 121 | MP0009672_abnormal_birth_weight | 0.51919385 |
| 122 | MP0010768_mortality/aging | 0.51831601 |
| 123 | MP0003879_abnormal_hair_cell | 0.51711880 |
| 124 | MP0004510_myositis | 0.51081829 |
| 125 | MP0003956_abnormal_body_size | 0.50131388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.11371550 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.11371550 |
| 3 | Neurofibrillary tangles (HP:0002185) | 5.79021198 |
| 4 | Myokymia (HP:0002411) | 4.88763214 |
| 5 | Abnormality of the corticospinal tract (HP:0002492) | 4.83803398 |
| 6 | Cerebral inclusion bodies (HP:0100314) | 4.33494511 |
| 7 | Peripheral hypomyelination (HP:0007182) | 4.33356158 |
| 8 | Focal motor seizures (HP:0011153) | 4.31995905 |
| 9 | Sensory axonal neuropathy (HP:0003390) | 4.09958097 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 4.09587162 |
| 11 | Febrile seizures (HP:0002373) | 3.96228036 |
| 12 | Diplopia (HP:0000651) | 3.87339586 |
| 13 | Abnormality of binocular vision (HP:0011514) | 3.87339586 |
| 14 | Spastic gait (HP:0002064) | 3.86121614 |
| 15 | Dysmetria (HP:0001310) | 3.76296000 |
| 16 | Cerebral hypomyelination (HP:0006808) | 3.68966895 |
| 17 | Parakeratosis (HP:0001036) | 3.64080025 |
| 18 | Intention tremor (HP:0002080) | 3.55390749 |
| 19 | Onion bulb formation (HP:0003383) | 3.53147309 |
| 20 | Termporal pattern (HP:0011008) | 3.44594408 |
| 21 | Insidious onset (HP:0003587) | 3.44594408 |
| 22 | Ankle clonus (HP:0011448) | 3.38814346 |
| 23 | Scanning speech (HP:0002168) | 3.30487248 |
| 24 | Visual hallucinations (HP:0002367) | 3.21361870 |
| 25 | Abnormal auditory evoked potentials (HP:0006958) | 3.21326194 |
| 26 | Annular pancreas (HP:0001734) | 3.17991784 |
| 27 | Obstructive sleep apnea (HP:0002870) | 3.16343579 |
| 28 | Focal seizures (HP:0007359) | 3.10705667 |
| 29 | Alacrima (HP:0000522) | 2.99442073 |
| 30 | Action tremor (HP:0002345) | 2.96507061 |
| 31 | Epileptic encephalopathy (HP:0200134) | 2.93470565 |
| 32 | Bundle branch block (HP:0011710) | 2.91266172 |
| 33 | Atonic seizures (HP:0010819) | 2.89335938 |
| 34 | Fetal akinesia sequence (HP:0001989) | 2.86702466 |
| 35 | Tetraplegia (HP:0002445) | 2.85544205 |
| 36 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.81598646 |
| 37 | Depression (HP:0000716) | 2.80476040 |
| 38 | Nemaline bodies (HP:0003798) | 2.73129092 |
| 39 | Abnormal eating behavior (HP:0100738) | 2.72205926 |
| 40 | Hyporeflexia of lower limbs (HP:0002600) | 2.71438671 |
| 41 | Muscle fiber inclusion bodies (HP:0100299) | 2.70158463 |
| 42 | Insomnia (HP:0100785) | 2.66792455 |
| 43 | Broad-based gait (HP:0002136) | 2.65666933 |
| 44 | Akinesia (HP:0002304) | 2.65096157 |
| 45 | Slow saccadic eye movements (HP:0000514) | 2.63683114 |
| 46 | Leukodystrophy (HP:0002415) | 2.61822838 |
| 47 | Torticollis (HP:0000473) | 2.59960155 |
| 48 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.59795535 |
| 49 | Urinary urgency (HP:0000012) | 2.59489098 |
| 50 | Retinal dysplasia (HP:0007973) | 2.57556660 |
| 51 | Poor eye contact (HP:0000817) | 2.57315785 |
| 52 | Rigidity (HP:0002063) | 2.52738488 |
| 53 | Lower limb muscle weakness (HP:0007340) | 2.52545728 |
| 54 | Clumsiness (HP:0002312) | 2.51102422 |
| 55 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.49262359 |
| 56 | Papilledema (HP:0001085) | 2.48838369 |
| 57 | Gaze-evoked nystagmus (HP:0000640) | 2.47907435 |
| 58 | Thickened helices (HP:0000391) | 2.46440204 |
| 59 | Exercise-induced myalgia (HP:0003738) | 2.44398651 |
| 60 | Dysdiadochokinesis (HP:0002075) | 2.43957349 |
| 61 | CNS hypomyelination (HP:0003429) | 2.41870383 |
| 62 | Apathy (HP:0000741) | 2.38652163 |
| 63 | Delusions (HP:0000746) | 2.38515490 |
| 64 | Decreased lacrimation (HP:0000633) | 2.38366353 |
| 65 | Morphological abnormality of the inner ear (HP:0011390) | 2.37043394 |
| 66 | Hyperventilation (HP:0002883) | 2.36844591 |
| 67 | Rapidly progressive (HP:0003678) | 2.35886566 |
| 68 | Pheochromocytoma (HP:0002666) | 2.34422589 |
| 69 | Myopathic facies (HP:0002058) | 2.33951280 |
| 70 | Megalencephaly (HP:0001355) | 2.32839284 |
| 71 | Exercise-induced muscle cramps (HP:0003710) | 2.31622739 |
| 72 | Hemiplegia (HP:0002301) | 2.30884134 |
| 73 | Dialeptic seizures (HP:0011146) | 2.30212938 |
| 74 | Bradykinesia (HP:0002067) | 2.30156636 |
| 75 | Spastic paraparesis (HP:0002313) | 2.29056839 |
| 76 | Heart block (HP:0012722) | 2.27520362 |
| 77 | Anteriorly placed anus (HP:0001545) | 2.26440266 |
| 78 | Cerebral hemorrhage (HP:0001342) | 2.24973846 |
| 79 | Hypoplastic pelvis (HP:0008839) | 2.24588544 |
| 80 | Status epilepticus (HP:0002133) | 2.21997910 |
| 81 | Increased circulating renin level (HP:0000848) | 2.21765491 |
| 82 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.21509610 |
| 83 | Progressive inability to walk (HP:0002505) | 2.19709067 |
| 84 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.18397092 |
| 85 | Aplasia of the phalanges of the hand (HP:0009802) | 2.18397092 |
| 86 | Aplasia involving bones of the extremities (HP:0009825) | 2.18397092 |
| 87 | Focal dystonia (HP:0004373) | 2.17899799 |
| 88 | Progressive cerebellar ataxia (HP:0002073) | 2.16930554 |
| 89 | Abnormal atrioventricular conduction (HP:0005150) | 2.16358688 |
| 90 | Diminished motivation (HP:0000745) | 2.15898158 |
| 91 | Split foot (HP:0001839) | 2.15600350 |
| 92 | Increased serum pyruvate (HP:0003542) | 2.15382558 |
| 93 | Abnormality of glycolysis (HP:0004366) | 2.15382558 |
| 94 | Abnormal social behavior (HP:0012433) | 2.14695753 |
| 95 | Impaired social interactions (HP:0000735) | 2.14695753 |
| 96 | Turricephaly (HP:0000262) | 2.13329709 |
| 97 | Epileptiform EEG discharges (HP:0011182) | 2.12325014 |
| 98 | EMG: myopathic abnormalities (HP:0003458) | 2.12110753 |
| 99 | Spastic tetraparesis (HP:0001285) | 2.11815469 |
| 100 | Lower limb amyotrophy (HP:0007210) | 2.11246751 |
| 101 | Bowel incontinence (HP:0002607) | 2.09206291 |
| 102 | Clonus (HP:0002169) | 2.07928490 |
| 103 | Diminished movement (HP:0002374) | 2.06253254 |
| 104 | Truncal ataxia (HP:0002078) | 2.06085034 |
| 105 | Absent septum pellucidum (HP:0001331) | 2.05196078 |
| 106 | Metabolic alkalosis (HP:0200114) | 2.04987250 |
| 107 | Generalized myoclonic seizures (HP:0002123) | 2.04723130 |
| 108 | Craniofacial dystonia (HP:0012179) | 2.03954596 |
| 109 | Neuroendocrine neoplasm (HP:0100634) | 2.01869705 |
| 110 | Abnormality of the lower motor neuron (HP:0002366) | 2.01627643 |
| 111 | Generalized tonic-clonic seizures (HP:0002069) | 2.01477303 |
| 112 | Premature skin wrinkling (HP:0100678) | 2.00818478 |
| 113 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.00265403 |
| 114 | Sleep apnea (HP:0010535) | 1.98310564 |
| 115 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.97311944 |
| 116 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.96603268 |
| 117 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.95728426 |
| 118 | Abnormality of saccadic eye movements (HP:0000570) | 1.95491659 |
| 119 | Foot dorsiflexor weakness (HP:0009027) | 1.95323932 |
| 120 | Absence seizures (HP:0002121) | 1.95127975 |
| 121 | Stridor (HP:0010307) | 1.94800512 |
| 122 | White forelock (HP:0002211) | 1.90863229 |
| 123 | Decreased motor nerve conduction velocity (HP:0003431) | 1.90234765 |
| 124 | Abnormal large intestine physiology (HP:0012700) | 1.90013718 |
| 125 | Autoamputation (HP:0001218) | 1.89336811 |
| 126 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.89290096 |
| 127 | Urinary incontinence (HP:0000020) | 1.89008664 |
| 128 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.88297663 |
| 129 | Impaired smooth pursuit (HP:0007772) | 1.87590167 |
| 130 | Slow progression (HP:0003677) | 1.87317651 |
| 131 | Poor speech (HP:0002465) | 1.86608937 |
| 132 | Anxiety (HP:0000739) | 1.86328765 |
| 133 | EEG with generalized epileptiform discharges (HP:0011198) | 1.85804032 |
| 134 | Neuronal loss in central nervous system (HP:0002529) | 1.84975272 |
| 135 | Blue irides (HP:0000635) | 1.83908095 |
| 136 | Hammertoe (HP:0001765) | 1.83543258 |
| 137 | Coronal craniosynostosis (HP:0004440) | 1.82886142 |
| 138 | Hemiparesis (HP:0001269) | 1.82721558 |
| 139 | Choreoathetosis (HP:0001266) | 1.82628567 |
| 140 | Patchy hypopigmentation of hair (HP:0011365) | 1.78825924 |
| 141 | Limb dystonia (HP:0002451) | 1.78301590 |
| 142 | Distal sensory impairment (HP:0002936) | 1.78205061 |
| 143 | Cupped ear (HP:0000378) | 1.78179601 |
| 144 | Abnormality of the foot musculature (HP:0001436) | 1.76679675 |
| 145 | Mutism (HP:0002300) | 1.75158613 |
| 146 | Paraparesis (HP:0002385) | 1.75105554 |
| 147 | Hypoplasia of the iris (HP:0007676) | 1.73030298 |
| 148 | Postural instability (HP:0002172) | 1.72491088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.43459357 |
| 2 | OXSR1 | 4.07517400 |
| 3 | EPHA4 | 2.96918143 |
| 4 | CDK19 | 2.58856803 |
| 5 | EPHB1 | 2.39597877 |
| 6 | BCR | 2.33557149 |
| 7 | PKN1 | 2.31694695 |
| 8 | TNIK | 2.28764083 |
| 9 | RIPK1 | 2.25563313 |
| 10 | CAMKK1 | 2.18532796 |
| 11 | WNK4 | 2.09955710 |
| 12 | NTRK3 | 2.02039986 |
| 13 | MAPKAPK5 | 1.88213850 |
| 14 | FGFR2 | 1.87510128 |
| 15 | PAK6 | 1.85942021 |
| 16 | UHMK1 | 1.84984148 |
| 17 | WNK1 | 1.83559443 |
| 18 | NTRK1 | 1.82875662 |
| 19 | LATS2 | 1.79210626 |
| 20 | PNCK | 1.72826903 |
| 21 | CASK | 1.69664941 |
| 22 | PRPF4B | 1.67271221 |
| 23 | LIMK1 | 1.61354148 |
| 24 | CAMK2B | 1.60826418 |
| 25 | MAP3K9 | 1.56586349 |
| 26 | MARK1 | 1.55033930 |
| 27 | TESK2 | 1.54377058 |
| 28 | TYRO3 | 1.53972114 |
| 29 | TESK1 | 1.49647356 |
| 30 | TRIB3 | 1.47305943 |
| 31 | MET | 1.47050543 |
| 32 | KSR2 | 1.43907716 |
| 33 | NEK6 | 1.40587185 |
| 34 | PBK | 1.38949870 |
| 35 | ICK | 1.37140106 |
| 36 | FGR | 1.34038967 |
| 37 | ROCK2 | 1.33325844 |
| 38 | CSNK1G3 | 1.32839535 |
| 39 | ARAF | 1.31569075 |
| 40 | DAPK1 | 1.29368826 |
| 41 | CSNK1A1L | 1.29129128 |
| 42 | CAMK2D | 1.26395160 |
| 43 | SGK223 | 1.24316077 |
| 44 | SGK494 | 1.24316077 |
| 45 | CDK5 | 1.22467123 |
| 46 | OBSCN | 1.19741247 |
| 47 | CSNK1G2 | 1.17334769 |
| 48 | PRKD3 | 1.14431569 |
| 49 | MAPK12 | 1.12514071 |
| 50 | ALK | 1.09669066 |
| 51 | MAP3K13 | 1.07810221 |
| 52 | PINK1 | 1.05317670 |
| 53 | CAMK2A | 1.04457196 |
| 54 | CAMK2G | 1.02106675 |
| 55 | MINK1 | 1.00959774 |
| 56 | NTRK2 | 1.00746175 |
| 57 | FES | 0.97394213 |
| 58 | SGK3 | 0.97011734 |
| 59 | DAPK2 | 0.96833394 |
| 60 | CDK14 | 0.95803124 |
| 61 | CLK1 | 0.95010064 |
| 62 | CSNK1G1 | 0.94970279 |
| 63 | MST4 | 0.92852486 |
| 64 | MAP3K4 | 0.92237099 |
| 65 | MAPK13 | 0.91263719 |
| 66 | PAK3 | 0.89538877 |
| 67 | CDK15 | 0.88497565 |
| 68 | BRAF | 0.88141093 |
| 69 | IRAK2 | 0.86974464 |
| 70 | MARK2 | 0.85703013 |
| 71 | CDK18 | 0.85657176 |
| 72 | MAP3K2 | 0.82515625 |
| 73 | PDPK1 | 0.80640201 |
| 74 | SGK2 | 0.80355686 |
| 75 | STK38 | 0.78753113 |
| 76 | CDK11A | 0.78719193 |
| 77 | PLK2 | 0.71032926 |
| 78 | PHKG2 | 0.70052183 |
| 79 | PHKG1 | 0.70052183 |
| 80 | PRKCE | 0.70040281 |
| 81 | BRSK1 | 0.68741349 |
| 82 | CAMKK2 | 0.67888356 |
| 83 | PRKCQ | 0.67591939 |
| 84 | STK11 | 0.64450950 |
| 85 | PRKCH | 0.64376547 |
| 86 | PTK2B | 0.64225562 |
| 87 | MUSK | 0.64205480 |
| 88 | PRKD1 | 0.63196038 |
| 89 | MAP2K7 | 0.61186411 |
| 90 | CAMK4 | 0.60539106 |
| 91 | FYN | 0.60354836 |
| 92 | EEF2K | 0.59770851 |
| 93 | MAP3K11 | 0.59510700 |
| 94 | MAP2K4 | 0.58466233 |
| 95 | KSR1 | 0.57754264 |
| 96 | SIK2 | 0.57059983 |
| 97 | BMPR2 | 0.57053200 |
| 98 | RPS6KA3 | 0.56807713 |
| 99 | SCYL2 | 0.56533307 |
| 100 | PDK1 | 0.54975027 |
| 101 | GRK5 | 0.54806000 |
| 102 | PRKCG | 0.53668337 |
| 103 | CCNB1 | 0.51082538 |
| 104 | MAP3K1 | 0.49475822 |
| 105 | RIPK4 | 0.47690362 |
| 106 | DMPK | 0.46437500 |
| 107 | NME1 | 0.45717374 |
| 108 | MAPKAPK3 | 0.45613270 |
| 109 | DYRK2 | 0.45572122 |
| 110 | PRKG1 | 0.45374948 |
| 111 | CSNK1D | 0.43791009 |
| 112 | TAOK2 | 0.42615133 |
| 113 | SGK1 | 0.42169816 |
| 114 | MAP2K1 | 0.41589175 |
| 115 | CAMK1G | 0.41008839 |
| 116 | PRKCZ | 0.40325367 |
| 117 | DYRK1A | 0.40319993 |
| 118 | PRKACB | 0.40242087 |
| 119 | CSNK1A1 | 0.39988277 |
| 120 | TNK2 | 0.39235632 |
| 121 | ILK | 0.38195741 |
| 122 | RAF1 | 0.37572843 |
| 123 | CAMK1 | 0.36968718 |
| 124 | DAPK3 | 0.35645334 |
| 125 | ERBB4 | 0.35177972 |
| 126 | MAPK10 | 0.34659639 |
| 127 | TTN | 0.34488206 |
| 128 | MAP3K12 | 0.34078277 |
| 129 | RPS6KB1 | 0.33302996 |
| 130 | RET | 0.32727045 |
| 131 | PDGFRB | 0.32650682 |
| 132 | ROCK1 | 0.32451297 |
| 133 | PRKACA | 0.31708183 |
| 134 | BMPR1B | 0.30991040 |
| 135 | MOS | 0.30765041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.06797960 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.93178963 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.92877120 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.49751737 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.39450267 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.35640442 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.30382620 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 2.29610565 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.27628510 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.12253505 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.01664561 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 1.89442441 |
| 13 | Axon guidance_Homo sapiens_hsa04360 | 1.88490411 |
| 14 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.87266487 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.86280702 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.68218138 |
| 17 | Long-term depression_Homo sapiens_hsa04730 | 1.68207552 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.66664914 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.64733922 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 1.64592936 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.60491709 |
| 22 | Long-term potentiation_Homo sapiens_hsa04720 | 1.55789069 |
| 23 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.52203807 |
| 24 | Olfactory transduction_Homo sapiens_hsa04740 | 1.49589373 |
| 25 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.46965440 |
| 26 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.46366366 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.42021666 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.41610232 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.40973048 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.35188804 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.32894086 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31054352 |
| 33 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.29156613 |
| 34 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.28177718 |
| 35 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.19692174 |
| 36 | Renin secretion_Homo sapiens_hsa04924 | 1.18236013 |
| 37 | Taste transduction_Homo sapiens_hsa04742 | 1.16370563 |
| 38 | Alzheimers disease_Homo sapiens_hsa05010 | 1.15307180 |
| 39 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.09761212 |
| 40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.06652465 |
| 41 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.05729419 |
| 42 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.05218956 |
| 43 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.04449634 |
| 44 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.04137334 |
| 45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.04010213 |
| 46 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.01653803 |
| 47 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.01437739 |
| 48 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.00124317 |
| 49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98877655 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.98789232 |
| 51 | Insulin secretion_Homo sapiens_hsa04911 | 0.98733195 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.98000373 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97710334 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 0.96634907 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 0.96162959 |
| 56 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.95748838 |
| 57 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.93546363 |
| 58 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92877341 |
| 59 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.92673346 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91217343 |
| 61 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.89909355 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.89853842 |
| 63 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.89678878 |
| 64 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.89675908 |
| 65 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.88617732 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88390777 |
| 67 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87108800 |
| 68 | Bile secretion_Homo sapiens_hsa04976 | 0.85416966 |
| 69 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85171883 |
| 70 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83781336 |
| 71 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82805838 |
| 72 | Phototransduction_Homo sapiens_hsa04744 | 0.81944976 |
| 73 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81685493 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.81449784 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79543452 |
| 76 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.78943048 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78566181 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.78316403 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.77620567 |
| 80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77050929 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76543366 |
| 82 | Tight junction_Homo sapiens_hsa04530 | 0.74758354 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.73783737 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72032717 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67884622 |
| 86 | Protein export_Homo sapiens_hsa03060 | 0.67459960 |
| 87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66725011 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65562989 |
| 89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65206797 |
| 90 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62678427 |
| 91 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62526445 |
| 92 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.59899571 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59359642 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59276522 |
| 95 | Melanogenesis_Homo sapiens_hsa04916 | 0.58057615 |
| 96 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.57712627 |
| 97 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57350457 |
| 98 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.57015639 |
| 99 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56784576 |
| 100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55632060 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55462755 |
| 102 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55352586 |
| 103 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54828131 |
| 104 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.52716780 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52206982 |
| 106 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51116763 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50217237 |
| 108 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48410241 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.48283906 |
| 110 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46128656 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.45428600 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42856097 |
| 113 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.42780882 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42188050 |
| 115 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40515690 |
| 116 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40459132 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38886825 |
| 118 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.38860249 |
| 119 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.38847476 |
| 120 | Alcoholism_Homo sapiens_hsa05034 | 0.38233090 |
| 121 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.36813918 |
| 122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36671321 |
| 123 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.36537205 |
| 124 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36413776 |
| 125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35355893 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34401962 |
| 127 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.33933757 |
| 128 | Phagosome_Homo sapiens_hsa04145 | 0.31635369 |
| 129 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31425908 |
| 130 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.29684770 |
| 131 | Glioma_Homo sapiens_hsa05214 | 0.28867053 |

